Category: BioTech
The analysis published under this category are as follows.
Monday, September 14, 2020
Why Bill Gates Is Betting Millions on Synthetic Biology / Companies / BioTech
By: John_Mauldin
By Justin Spittler: Beyond Meat (BYND) was one of last year’s hottest stocks. Shares of the plant-based meat company exploded 859% during its first three months out of the gate.
“Fake meat” was all the rage: an instant favorite with Millennials (I personally prefer the real thing). And the industry’s still booming today. It’s already worth $12 billion. By 2025, it’s projected to double again!
But here’s the thing: While most people have heard of Beyond Meat and the plant-based meat mania by now, they don’t realize that this is all part of a much bigger opportunity. In fact, many of the wealthiest investors on the planet have been going “all in” on this obscure megatrend.
Read full article... Read full article...
Monday, May 04, 2020
The Biotech Boom May Have Only Just Begun / Companies / BioTech
By: Submissions
“The world is moving so fast these days that the man who says it can't be done is generally interrupted by someone doing it.” ― Elbert Hubbard
A new medical development is sweeping the country…
Some may see it as controversial - but the studies don’t lie.
It’s effective.
So effective, in fact, that the FDA has just fast-tracked approval for research…
Meaning that it is aiming to gain a major stake in a key healthcare market that is on track to hit $260 billion in the next six years.
Saturday, February 15, 2020
iShares Nasdaq Biotechnology ETF IBB AI Mega-trend Tech Stocks Investing 2020 / / BioTech
By: Nadeem_Walayat
The juggernaut that is Artificial Intelligence continues to rumble along towards an inexorable future, one that most still fail to grasp the magnitude of the changes that are just around the corner as humans think in linear terms whilst the AI trend is EXPONENTIAL. Where developments that even the proponents of AI thought would take several years are taking place in mere MONTHS! That is the power of the unfolding AI MEGA-TREND!
AI has already CHANGED THE WORLD! EXPONENTIALLY! You have an AI super computer right in your pocket for likely less than £1000!
Especially, when one marries AI with other big world changing tech mega-trend "Quantum Computing"! Put the 2 together and we are literally going to see an explosion in SUPER INTELLGENCE that would soon far exceed that of human intelligence, following which it won't be that many years before the AI exceeds the intelligence of the sum of ALL humans! For better or worse, that's the path we are on.
And all those who say AI can be controlled are going to be proven wrong, as new technologies tend to be first sequestered towards military aims. So whilst we focus on the benefits of AI in reality AI is a POWERFUL WEAPON and so the world is in an AI arms race, commercial, economic and military AI arms race.
Read full article... Read full article...
Wednesday, August 28, 2019
Highly Undervalued Biotechnology Stocks To Watch / Companies / BioTech
By: Joshua_Rodriguez
The biotechnology industry is an exciting one. As continued innovation drives a better scientific understanding of the human body and the ailments that weigh on it, we are seeing better outcomes for patients who are living longer, more fulfilling lives.However, it’s not only the patients that are seeing tremendous benefit out of this innovation. Investors are benefiting greatly as well. After all, as new medications hit the market, tremendous revenue opportunities are being created for the companies creating these treatments.
Read full article... Read full article...
Saturday, July 27, 2019
Human Life Extension Investing in IBB - iShares Nasdaq Biotechnology ETF - IBB / Companies / BioTech
By: Nadeem_Walayat
We are currently galloping full speed along an exponential curve that unlike the neural nets of the 1990's, that promised a lot but delivered very little, this time it really looks like we are on the verge of AI success, not only that but it heralds changes in every aspect of our lives most of which we cannot even imagine today, hence the term the singularity is often used, the AI event horizon beyond which we cannot see.
My latest analysis in this series focuses on how to profit and capitalise on the unfolding machine intelligence driven mega-trend through investing in leveraged to AI Human Life Extension stocks.
Read full article... Read full article...
Thursday, July 18, 2019
Biotech Stocks With Near Term Catalysts / Companies / BioTech
By: Joshua_Rodriguez
Medical innovation is an incredible thing. In fact, as we continue to better understand the human body and cutting-edge biotechnology companies continue to produce innovative medicines, the average life expectancy in human beings is growing at a rate of about two months every year.Not only is this innovation in medicine leading to a better quality of life and longer lifespan for countless patients, it is also leading strong investment opportunities. Driven by the fact that there are multiple catalysts along the process of drug development and incredible value once new drugs are approved, investor interest in the field of biotechnology is running high.
Read full article... Read full article...
Wednesday, April 17, 2019
Elliott Wave Analysis of XBI (Biotech ETF) / Companies / BioTech
By: WavePatternTraders
This is one area of the market that is actually showing some weakness compared to the NDX and SPX, so it could be a warning for both those markets. The reversal from the last minor swing high at $93.87 could be favoring a peak in place, although I would still allow for a bit more upside to end wave [B] if needed.As long as it fails to make a new high above $101.52, then it has a bearish setup for a move lower and tests $60.00 - 55.00 to end wave [C] to complete a large 3 wave decline from $101.52.
Bearish below $101.52, but tentatively looking lower below $93.87.
Read full article... Read full article...
Monday, April 08, 2019
5 Biotech Stocks That You Should Be Watching Right Now! / Companies / BioTech
By: Submissions
The world of biotechnology is changing rapidly. Today, there are more answers for medical questions than ever before. However, that doesn’t mean that innovation is coming to an end. Several companies dedicate their efforts to finding solutions for some of the world’s most debilitating conditions.
This medical innovation has led to droves of investor interest. As more and more companies find solutions, more and more investors are finding profits. However, as with any investment, investing in the biotechnology space can come with risk.
Read full article... Read full article...
Friday, November 23, 2018
DNA Breakthrough: Scientists Repair Genes in Human Embryos / Companies / BioTech
By: Andrew_Cioffi
The medical field is set to change tremendously owing to a recent breakthrough by medical researchers. A team of researchers recently managed to use gene-editing tools to remove mutations in embryos which develop into human diseases. The team that comprised of the Oregon Health and Science University and other researchers were able to make breakthrough discoveries. The particular disease, hypertrophic cardiomyopathy, is passed down genetically and is a cause of many deaths especially among young athletes. It is not clear yet as to when the technology will be applied in the real world.
Read full article... Read full article...
Thursday, May 03, 2018
4 Biotech Stock Movers to Watch / Companies / BioTech
By: Harry_Boxer
Biotechs continue to dominate our list of top charts to watch.
CASI Pharmaceuticals Inc. (CASI) rose 48 cents, or 7.2%, to $7.14 on 773,700 shares Tuesday. The move came on no news, although the stock soared in early April on news that China's Food and Drug Administration (CFDA) would convene a panel to discuss its cancer therapy, Evomela. The stock has been flagging since that move, but may be positioning to break out, with the next target at $10.
Read full article... Read full article...
Monday, September 11, 2017
Could This Be The Biggest Biotech Breakthrough Of The Year? / Companies / BioTech
By: OilPrice_Com
Someone dies of a stroke every 4 minutes in the United States. Globally, 15 million people suffer a stroke every year. It’s debilitating physically and financially—but one little-known company has developed a medical device that hopes to challenge that deadly statistic.
It’s been quietly developing this new technology for 10 years. Now it’s released updated preliminary clinical trial results, and signed a manufacturing deal which could make a significant impact in the medical device industry.
After a decade of painstaking development, we’re now nearing the end of the long road to validation, and for investors who understand this industry, this could be the critical juncture.
Read full article... Read full article...
Wednesday, July 19, 2017
Biotech with Alzheimer's Focus Makes Progress on Several Fronts / Companies / BioTech
By: TLSReport
In its corporate update for Q2/17, a Canada-based biotech targeting neurological disorders including Alzheimer's disease informed investors of advancements in several programs, including designation of a second validated lead compound in development.
Among ProMIS Neurosciences Inc.'s (PMN:TSE) "key accomplishments" in the quarter, the company noted it expanded its potentially "best in class amyloid-beta (Aβ) portfolio for Alzheimer's disease," according to a July 10 news release. In its oral presentation, the company stressed its emphasis on the "best in class" goal, noting that even though Biogen Inc.'s (BIIB:NASDAQ) aducanumab will be "first in class" and is progressing well in development, the ProMIS compound could be more selective and possess greater patient benefits.
Read full article... Read full article...
Sunday, April 23, 2017
After The Crash - Digital And Regenerative Medicine, Live for Ever! / Companies / BioTech
By: John_Rubino
For most people, the doctor visit hasn’t changed in decades. Same physical waiting rooms, same paper forms to fill out, same slow, expensive tests and marginally-effective, maximally-invasive treatments. But that’s about to change, as a wave of new technologies drag medicine into the 21st century. Among the most interesting:
Tuesday, April 18, 2017
The Smart Money Is Piling Into Regenerative Medicine / Companies / BioTech
By: John_Mauldin
BY PATRICK COX : The Congressional Budget Office released its long-term budget outlook. This report should have sparked a national discussion about societal aging, but big media largely ignored it.
Fortunately, there are signs that smart investors are hedging this failure by investing in regenerative medicine (RM).
Read full article... Read full article...
Wednesday, April 05, 2017
British Billionaire Jim Mellon Says Biotech Is the Best Investment Now / Companies / BioTech
By: John_Mauldin
BY PATRICK COX : We are in the midst of an unprecedented change. Life spans have nearly doubled since the beginning of the 20th century. In addition, recent advances in computer technology have had a huge impact on biological sciences, which means this trend will accelerate.
Still, most people think that the process of aging will go on pretty much as it is now. They’re wrong.
Read full article... Read full article...
Monday, March 13, 2017
... / Companies / BioTech
By: OilPrice_Com
...
Tuesday, February 28, 2017
Major Funds Betting On Trump BioTech Sector / Companies / BioTech
By: TLSReport
Donald Trump's presidency is a real nitro boost for the future of the biotech sector in the U.S., says Tom Beck, editor of Portfolio Wealth Global.
Donald Trump's presidency is a massive boost to all industries, and is a real nitro boost for the future of the biotech sector in the U.S.
With 80 million baby-boomers looking to stay young and vital for a very long time, you should be making your move, and market-beating returns will be occurring from the large-cap stocks and in the small-cap sector even more so.
Read full article... Read full article...
Tuesday, January 24, 2017
The Last Time This Happened, Biotech Stocks Plunged by 50% / Companies / BioTech
By: John_Mauldin
BY PATRICK WATSON : “They’re getting away with murder,” said Donald Trump at last week’s epic news conference.
No, he didn’t mean Russian hackers. He was talking about red-blooded American drug companies.
Trump went on: “Pharma has a lot of lobbyists and a lot of power, and there is very little bidding. We’re the largest buyer of drugs in the world, and yet we don’t bid properly, and we’re going to save billions of dollars.”
Read full article... Read full article...
Wednesday, January 18, 2017
Biotech Breakthrough Could Create A $11.4 Trillion Opportunity / Companies / BioTech
By: OilPrice_Com
....
Saturday, December 03, 2016
Can Biotech's Trump Bump Last? / Companies / BioTech
By: TLSReport
In the weeks since Donald Trump's presidential election victory, the stock markets have ridden a wave into positive—and in the case of the Dow, record-breaking—territory. The so-called Trump Bump also sent biotech indices, flaccid for much of the year, up as much as 15%. With the election now nearly a month old, and hot-button issues such as drug pricing still in the press, industry watchers have begun to weigh in on what might happen in the biotech and pharma markets when Trump takes office.
Read full article... Read full article...